Plasmid-encoded neurotoxin genes in clostridium botulinum serotype a subtypes

Abstract

The present invention provides a novel isolated plasmid, wherein the plasmid is a native plasmid found in unique C. botulinum type A strains and encode either BoNT/A3 or BoNT/A4 and BoNT/B. The present invention also provides a method of obtaining a plasmid-encoded botulinum neurotoxin and botulinum neurotoxin complex comprising the step of isolating a plasmid encoding the cntA/A or cntA/B neurotoxin gene and genes encoding protein components of the toxin complex from a C. botulinum type A strain. The inventors performed comparative analyses of representative BoNT/A subtype strains by pulsed-field gel electrophoresis (PFGE) and Southern hybridizations with probes specific for the BoNT/A and B genes, cntA/A and cntA/B. Unexpectedly, the inventors determined that the genes encoding BoNT/A3 in the A3 strain, and BoNT/A4 and BoNT/B in the A4 strain, are on plasmids.

1 . A method of obtaining a plasmid-encoded botulinum neurotoxin comprising the steps of:
 obtaining a bacterial strain comprising a plasmid-encoded botulinum neurotoxin type A,   identifying a plasmid encoding the cntA/A or cntA/B gene from the bacterial strain, wherein (a) the cntA/A or cntA/B gene encodes BoNT/A3, and the bacterial strain is  Clostridium botulinum  type A strain Loch Maree; or (b) the cntA/A or cntA/B gene encodes BoNT/A4 and BoNT/B5, and the bacterial strain is  Clostridium botulinum  type A strain 657Ba;   separating and purifying the plasmid encoding the cntA/A or cntA/B gene from the  Clostridium botulinum  type A strain; and   introducing the plasmid into a clostridium bacteria and culturing the  Clostridium  bacteria, whereby a plasmid-encoded botulinum neurotoxin is obtained.   
     
     
         2 . The method of  claim 1  wherein the  Clostridium botulinum  type A strain is Loch Maree. 
     
     
         3 . The method of  claim 1  wherein the  Clostridium botulinum  type A strain is 657Ba. 
     
     
         4 . A method of producing botulinum neurotoxins and botulinum neurotoxin complexes comprising the steps of:
 a) isolating a plasmid encoding the cntA/A or cntA/B gene from a  Clostridium botulinum  type A strain, wherein (a) the cntA/A or cntA/B gene encodes BoNT/A3, and the  Clostridium botulinum  type A strain is Loch Maree; or (b) the cntA/A or cntA/B gene encodes BoNT/A4 and BoNT/B5, and the  Clostridium botulinum  type A strain is 657Ba;   b) separating and purifying the plasmid encoding the cntA/A or cntA/B gene from the  Clostridium botulinum  type A strain;   c) introducing the plasmid into  clostridium  bacteria; and   d) culturing the clostridium bacteria wherein the  botulinum  toxin complex and neurotoxins are produced and purified.   
     
     
         5 . The method of  claim 4  wherein the  Clostridium botulinum  type A strain is Loch Maree. 
     
     
         6 . The method of  claim 4  wherein the  Clostridium botulinum  type A strain is 657Ba.